{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:30:02Z","timestamp":1789684202570,"version":"4.0.1"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T00:00:00Z","timestamp":1646006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Serum cytokines\u2014reflecting systemic inflammation has been associated with the risk of decompensation and mortality in patients with cirrhosis. However, the role of systemic inflammation in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt procedure remains unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and Methods<\/jats:title><jats:p>Patients with cirrhosis who received transjugular intrahepatic portosystemic shunt between June 2015 and September 2017 were included. Portal and hepatic venous blood samples were obtained intraoperatively; serum cytokine levels (IL-10, IL-17A, IL-1RA, IL-8, and CXCL10) were measured in 105 patients. Associations with survival and other outcomes during long-term follow-up (median: 1,564 days) were assessed using logistic regression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>IL-17A and CXCL10 levels were higher in the portal than in the hepatic veins, whereas IL-1RA levels were higher in the hepatic than in the portal veins. However, IL-8 or IL-10 levels between hepatic and portal veins showed no differences. Multivariate analysis demonstrated that Child\u2013Pugh scores (<jats:italic>P<\/jats:italic> = 0.017, HR: 1.484, 95% CI: 1.072\u20132.055) and IL-8 level in hepatic veins (<jats:italic>P<\/jats:italic> &amp;lt; 0.001, HR: 1.043, 95% CI: 1.019\u20131.068) were independent predictors for mortality during long-term follow-up, with an optimal cut-off of 5.87 pg\/ml for IL-8 in hepatic veins. Patients with hepatic IL-8 levels &amp;lt; 5.87 pg\/ml had significantly higher cumulative survival rates (98.4 vs. 72.9% at 1 year, 98.4 vs. 65.3% at 2 years, 96.7 vs. 60.3% at 3 years, 94.2 vs. 60.3% at 4 years; <jats:italic>P<\/jats:italic> &amp;lt; 0.0001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>IL-8 levels in hepatic veins may reflect liver cirrhosis severity. Elevated IL-8 levels suggest shorter survival in patients receiving TIPS.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.829245","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T05:47:29Z","timestamp":1646027249000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["High Interleukin-8 Levels Associated With Decreased Survival in Patients With Cirrhosis Following Transjugular Intrahepatic Portosystemic Shunt"],"prefix":"10.3389","volume":"9","author":[{"given":"Guofeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoze","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0168-8278(00)80422-5","article-title":"Complications of cirrhosis","volume":"32","author":"Bosch","year":"2000","journal-title":"I Portal hypertension J Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1002\/hep.29104","article-title":"Left ventricular systolic function is associated with sympathetic nervous activity and markers of inflammation in cirrhosis","volume":"65","author":"Yotti","year":"2017","journal-title":"Hepatology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jhep.2014.03.014","article-title":"Inflammation and portal hypertension - the undiscovered country","volume":"61","author":"Mehta","year":"2014","journal-title":"J Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","article-title":"Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis","volume":"63","author":"Bernardi","year":"2015","journal-title":"J Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jhep.2020.10.004","article-title":"Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality","volume":"74","author":"Costa","year":"2021","journal-title":"J Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"16996","DOI":"10.3748\/wjg.v20.i45.16996","article-title":"Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications","volume":"20","author":"Siramolpiwat","year":"2014","journal-title":"World J Gastroenterol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1007\/s10620-013-2578-0","article-title":"Long-term follow-up of TIPS created with expanded poly-tetrafluoroethylene covered stents","volume":"58","author":"Sajja","year":"2013","journal-title":"Dig Dis Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jhep.2014.09.032","article-title":"CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt","volume":"62","author":"Berres","year":"2015","journal-title":"J Hepatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/liv.12922","article-title":"Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt","volume":"36","author":"Berres","year":"2016","journal-title":"Liver Int."},{"key":"B10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/liv.13610","article-title":"Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortality","volume":"38","author":"Lehmann","year":"2018","journal-title":"Liver Int."},{"key":"B11","doi-asserted-by":"publisher","first-page":"707254","DOI":"10.1155\/2015\/707254","article-title":"Serum cytokine of IL-10 and IL-12 in chronic liver disease: the immune and inflammatory response","volume":"2015","author":"El-Emshaty","year":"2015","journal-title":"Dis Markers."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure","volume":"64","author":"Cl\u00e0ria","year":"2016","journal-title":"Hepatology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/MEG.0b013e328351db6e","article-title":"High-sensitivity C-reactive protein levels predict survival and are related to haemodynamics in alcoholic cirrhosis","volume":"24","author":"Mortensen","year":"2012","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/j.1478-3231.2011.02504.x","article-title":"Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases","volume":"31","author":"Tacke","year":"2011","journal-title":"Liver Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.2047-6310.2011.00014.x","article-title":"Influence of elevated liver fat on circulating adipocytokines and insulin resistance in obese hispanic adolescents","volume":"7","author":"Kim","year":"2012","journal-title":"Pediatr Obes."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.clinbiochem.2011.09.017","article-title":"Some inflammatory cytokine levels, iron metabolism and oxidan stress markers in subjects with nonalcoholic steatohepatitis","volume":"44","author":"Uysal","year":"2011","journal-title":"Clin Biochem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1161\/ATVBAHA.108.162305","article-title":"A potential role of the CXC chemokine GROalpha in atherosclerosis and plaque destabilization: downregulatory effects of statins","volume":"28","author":"Breland","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1164\/ajrccm.164.3.2009052","article-title":"Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis","volume":"164","author":"Harbarth","year":"2001","journal-title":"Am J Respir Crit Care Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1034\/j.1600-0676.2000.020006442.x","article-title":"Neopterin and interleukin-8\u2013prognosis in alcohol-induced cirrhosis","volume":"20","author":"Homann","year":"2000","journal-title":"Liver."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/hep.1840200439","article-title":"Tumor necrosis factor-alpha regulates in vivo nitric oxide synthesis and induces liver injury during endotoxemia","volume":"20","author":"Harbrecht","year":"1994","journal-title":"Hepatology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1111\/j.1523-5378.2007.00545.x","article-title":"Plasma levels of interleukin-6 and interleukin-8 in Chinese patients with non-alcoholic fatty liver disease","volume":"54","author":"Chu","year":"2007","journal-title":"Hepatogastroenterology."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.3390\/ijms21114189","article-title":"Relationship between IL-8 circulating levels and TLR2 hepatic expression in women with morbid obesity and nonalcoholic steatohepatitis","volume":"21","author":"Auguet","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nm1551","volume":"13","year":"2007","journal-title":"Nat Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e83341","DOI":"10.1371\/journal.pone.0083341","article-title":"Soluble TNF-alpha-receptors I are prognostic markers in TIPS-treated patients with cirrhosis and portal hypertension","volume":"8","author":"Trebicka","year":"2013","journal-title":"PLoS ONE."},{"key":"B25","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1586\/1744666X.2014.894886","article-title":"The CXCL8\/IL-8 chemokine family and its receptors in inflammatory diseases","volume":"10","author":"Russo","year":"2014","journal-title":"Expert Rev Clin Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0014-5793(92)80909-Z","article-title":"Interleukin-8, a chemotactic and inflammatory cytokine","volume":"307","author":"Baggiolini","year":"1992","journal-title":"FEBS Lett."},{"key":"B27","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1440-1746.1996.tb00306.x","article-title":"Plasma interleukin-8 levels in patients with post-hepatitic cirrhosis: relationship to severity of liver disease, portal hypertension and hyperdynamic circulation","volume":"11","author":"Li","year":"1996","journal-title":"J Gastroenterol Hepatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ccell.2016.05.020","article-title":"Metabolic inflammation-associated IL-17A causes non-alcoholic steatohepatitis and hepatocellular carcinoma","volume":"30","author":"Gomes","year":"2016","journal-title":"Cancer Cell."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.829245\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T05:47:32Z","timestamp":1646027252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.829245\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,28]]},"references-count":29,"alternative-id":["10.3389\/fmed.2022.829245"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.829245","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,28]]},"article-number":"829245"}}